2020-03-01
Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151–6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
Publication
Publication
European Urology : Official Journal of the European Association of Urology , Volume 77 - Issue 3 p. e76- e77
Additional Metadata | |
---|---|
doi.org/10.1016/j.eururo.2019.09.030, hdl.handle.net/1765/124192 | |
European Urology : Official Journal of the European Association of Urology | |
Organisation | Department of Medical Oncology |
de Joode, K. (Karlijn), & van der Veldt, A.A.M. (Astrid A.M.). (2020). Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151–6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?. European Urology : Official Journal of the European Association of Urology, 77(3), e76–e77. doi:10.1016/j.eururo.2019.09.030 |